7[3]Vandervoort J,Soetikno RM,Tham TC,Wong RC,Ferrari AP Jr,Montes H,Roston AD,Slivka A,Lichtenstein DR,Ruymann FW,Van Dam J,Hughes M,Carr-Locke DL.Risk factors for complications after performance of ERCP.Gastrointest Endosc 2002; 56:652-656
8[4]Cotton PB,Lehman G,Vennes J,Geenen JE,Russell RC,Meyers WC,Liguory C,Nickl N.Endoscopic sphincterotomy complications and their management:an attempt at consensus.Gastrointest Endosc 1991; 37:383-393
9[5]Smithline A,Silverman W,Rogers D,Nisi R,Wiersema M,Jamidar P,Hawes R,Lehman G.Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.Gastrointest Endosc 1993; 39:652-657
10[6]Tarnasky PR,Palesch YY,Cunningham JT,Mauldin PD,Cotton PB,Hawes RH.Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.Gastroenterology 1998; 115:1518-1524
8Güitrón-CantúA,Adalid-Martínez R,Gutiérrez-BermúdezJA,et al.Complications in diagnostic and therapeutic endo-scopic cholangiopancreatography.Prospective study[J].Rev Gastroenterol Mex,2007,72(3):227-235.
9Cotton PB,Lehman G,Vennes J,et al.Endoscopic sphinc-terotomy complicatuins and their management:an at-tempt at consensus[J].Gastrointest Endosc,1991,37(3):383-393.
10Freeman ML.Prevention of post-ERCP pancreatitis:phar-macologic solution or patient selection and pancreatic stents[J].Gastroenterology,2003,124(7):1977-1980.
